Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.575
+0.025 (1.61%)
At close: Jul 30, 2026, 4:00 PM EDT
1.541
-0.034 (-2.15%)
After-hours: Jul 30, 2026, 7:59 PM EDT
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $1.06M in the quarter ending March 31, 2026, with 45.54% growth. This brings the company's revenue in the last twelve months to $3.91M, up 33.26% year-over-year. In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%.
Revenue (ttm)
$3.91M
Revenue Growth
+33.26%
P/S Ratio
0.96
Revenue / Employee
$71,150
Employees
55
Market Cap
3.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.73K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| Vivos Therapeutics | 19.57M |
| WORK Medical Technology Group LTD | 9.85M |
| Beyond Air | 7.68M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| VolitionRx | 2.47M |
| Sintx Technologies | 1.03M |
INBS News
- 7 days ago - Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry - GlobeNewsWire
- 9 days ago - Intelligent Bio Solutions completes precision testing for drug screening system - TheFly
- 9 days ago - Intelligent Bio Solutions Slides: Corporate presentation - Filings
- 9 days ago - Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 6 weeks ago - Intelligent Bio Solutions Slides: Investor presentation - Filings
- 6 weeks ago - Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - GlobeNewsWire